HCID 10967937, 화합물 → HCID 10480471, 화합물

HRID 1179442노트

반응식

HRID 1179442 반응식
[CH3:1][O:2][CH:3]([O:19][CH3:20])[C@:4]1([CH3:18])[C@H:9]2[O:10][C@H:8]2[C:7]2[CH:11]=[C:12]([N+:15]([O-:17])=[O:16])[CH:13]=[CH:14][C:6]=2[O:5]1.[CH3:21][O:22][C:23]1[CH:28]=[CH:27][C:26]([NH:29][CH2:30][C:31]2[NH:32][CH:33]=[CH:34][N:35]=2)=[CH:25][CH:24]=1>>[CH3:1][O:2][CH:3]([O:19][CH3:20])[C@:4]1([CH3:18])[C@@H:9]([OH:10])[C@H:8]([N:29]([C:26]2[CH:27]=[CH:28][C:23]([O:22][CH3:21])=[CH:24][CH:25]=2)[CH2:30][C:31]2[NH:35][CH:34]=[CH:33][N:32]=2)[C:7]2[CH:11]=[C:12]([N+:15]([O-:17])=[O:16])[CH:13]=[CH:14][C:6]=2[O:5]1

참가 물질

3

실험 절차

The title compound (280 mg, 28%) was prepared using (2S,3S,4S)-3,4-dihydro-2-dimethoxymethyl-3,4-epoxy-2-methyl-6-nitro-2H-1-benzopyran (591 mg, 2.10 mmol) and 4-methoxyphenyl-1H-imidazol-2-ylmethylamine (427 mg, 2.10 mmol), according to the same procedure used for the preparation of example 1 above.

후처리

  1. customused for the preparation of example 1 above

출처 및 근거

ORD 기록
ord-d1772ee9637e4f9388538ebe8fbfa775
출처 데이터셋
uspto-grants-2007_10
특허 번호
US07279497B2

반응 노트

불러오는 중…